Erin Burkhart, GVP, Chief Accounting Officer: Biomarin Pharmaceutical BMRN Sell · Filed 24/08/15

Trade details

Type: Insider sale
Amount: $64,260
Shares · price: 714 sh · $90.00 a share
Held after: 14,449 sh
Stock: Biomarin Pharmaceutical BMRN
Person: Erin BurkhartGVP, Chief Accounting Officer
Trade date: 24/08/13
Filed: 24/08/15
Days to filing: 2 days

Sold 4.7% of holdings

Share of holding sold: 4.7%

Biomarin Pharmaceutical trades, last 26 weeks

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 24/07/14~24/09/12

Erin Burkhart's recent trades

Erin BurkhartGVP, Chief Accounting Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$105.9K
1,786 sh
$105.9K
Filed 25/05/20
Traded 25/05/20
Erin BurkhartOfficer
Planned sale10b5-1 planBiomarin Pharmaceutical
Planned sale10b5-1 plan
Biomarin Pharmaceutical
BMRN
$105.9K
1,786 sh
$105.9K
Filed 25/05/20
Traded 25/05/20
Erin BurkhartGVP, Chief Accounting Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$92.6K
1,295 sh
$92.6K
Filed 25/03/20
Traded 25/03/19
Erin BurkhartOfficer
Planned sale10b5-1 planBiomarin Pharmaceutical
Planned sale10b5-1 plan
Biomarin Pharmaceutical
BMRN
$92.6K
1,295 sh
$92.6K
Filed 25/03/19
Traded 25/03/19
Erin BurkhartGVP, Chief Accounting Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$91.9K
1,344 sh
$91.9K
Filed 25/02/25
Traded 25/02/24

Erin Burkhart, CAO — sold $64.3K of Biomarin Pharmaceutical BMRN · 4.7% of holdings · 10b5-1 plan | Whalegun